A meaningful career as a pharmaceutical statistician

10:45 am - 11:45 am, August 15

Speaker: Yili L. Pritchett, Ph.D

Neumora Therapeutics

Dr. Pritchett is VP, Head of Biometrics in Neumora Therapeutics. Prior to her current position, Dr. Pritchett was VP or SVP, Head of Biometrics for two other biotech companies and the Statistical Therapeutic Areas Head for 3 large pharmaceutical companies. Dr. Pritchett started her career by joining Eli Lilly as a Senior Statistician right after obtaining her PhD from the Dept of Statistics in University of Wisconsin – Madison. In her 30 years’ service to pharmaceutical industry, Dr. Pritchett has acquired extensive and solid knowledge of drug development in early or late phase clinical trials across broad therapeutic areas of Oncology, CNS, Immunology, Endocrinology, Respiratory, Infectious Disease, Vaccine, and Renal. She was intimately involved in regulatory interactions for compounds at various development stages from IND to Pre-NDA, and made significant contributions to the successful regulatory submission and approval of 8 drug products. Dr. Pritchett is passionate about using novel statistical methodology to solve challenging problems that inevitably exist in the journey of advancing a compound from lab bench to becoming a treatment option for patients. As a statistical leader for over 18 years, Dr. Pritchett led her teams to elevate statistical influence in drug development and deliver high quality quantitative solutions or results to enable informed decision making.

Dr. Pritchett has 79 published manuscripts or book chapters and 46 oral presentations at statistical or drug development conferences. She was elected as a Fellow of American Statistical Association in 2013.

Abstract

TBD